Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kent

Showing results (511-520 of 1,317) with videos related to

Pageof 132
Sort By:
Journal of Comparative Effectiveness Research|July 8, 2020
Why clinical trials may not help patients make treatment decisions: results from focus group discussions with 22 patientsThomas W Concannon, Christine M Lundquist, Jennifer S Lutz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Value of Risk-Stratified Information in the National Lung Cancer Screening TrialD I Soeteman, J T Cohen, P J Neumann, et al.
Circulation|October 1, 1976
Regional contractility. Selective depression of ischemic myocardium by verapamilH J Smith, R A Goldstein, J M Griffith, et al.
Health Affairs (Project Hope)|February 24, 2006
Health spending projections through 2015: changes on the horizonChristine Borger, Sheila Smith, Christopher Truffer, et al.
Chemical Research in Toxicology|February 21, 2006
Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6Ute M Kent, Hsia-Lien Lin, Danielle E Mills, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6Chitra Sridar, Ute M Kent, Lisa M Notley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseasesM Kent Froberg, Elizabeth Palavecino, Richard Dykoski, et al.
Lancet (London, England)|March 17, 2009
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysisThomas A Trikalinos, Alawi A Alsheikh-Ali, Athina Tatsioni, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2015
The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA StudyBenjamin S Wessler, David M Kent, David E Thaler, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2004
Metabolism of N,N',N"-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the inactivation of both isoforms by two distinct mechanismsErin Harleton, Marie Webster, Namandjé N Bumpus, et al.
Pageof 132

Showing results (511-520 of 1,317) with videos related to

Sort By:
Pageof 132
Journal of Comparative Effectiveness Research|July 8, 2020
Why clinical trials may not help patients make treatment decisions: results from focus group discussions with 22 patientsThomas W Concannon, Christine M Lundquist, Jennifer S Lutz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Value of Risk-Stratified Information in the National Lung Cancer Screening TrialD I Soeteman, J T Cohen, P J Neumann, et al.
Circulation|October 1, 1976
Regional contractility. Selective depression of ischemic myocardium by verapamilH J Smith, R A Goldstein, J M Griffith, et al.
Health Affairs (Project Hope)|February 24, 2006
Health spending projections through 2015: changes on the horizonChristine Borger, Sheila Smith, Christopher Truffer, et al.
Chemical Research in Toxicology|February 21, 2006
Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6Ute M Kent, Hsia-Lien Lin, Danielle E Mills, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6Chitra Sridar, Ute M Kent, Lisa M Notley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseasesM Kent Froberg, Elizabeth Palavecino, Richard Dykoski, et al.
Lancet (London, England)|March 17, 2009
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysisThomas A Trikalinos, Alawi A Alsheikh-Ali, Athina Tatsioni, et al.
Cerebrovascular Diseases (Basel, Switzerland)|July 18, 2015
The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA StudyBenjamin S Wessler, David M Kent, David E Thaler, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2004
Metabolism of N,N',N"-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the inactivation of both isoforms by two distinct mechanismsErin Harleton, Marie Webster, Namandjé N Bumpus, et al.
Pageof 132